AMaRC (Australasian Myeloma Research Consortium) Research Advisory Group Member
ALL-G Myeloma Working Group Scientific Meeting and Group Writing Lead
MM23 (SEALAND) – Phase III Randomised Trial of Selinexor and Lenalidomide Maintenance – Trial Management Committee
Australia/New Zealand Myeloma Ambassador Program
Wrote protocols for EVIQ: Weekly carfilzomib/dexamethasone; pomalidomide/bortezomib/dexamethasone; GRIFFIN RVD; RVD-lite; RVD-SWOG S0777.
Co-funding research project “Optimising Multiple Myeloma Services in NSW through the contribution of Myeloma Advanced Practice Nurses” by the NSW Myeloma Working Group
